Raymond James Financial’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
Raymond James Financial's VCYT Position: Q3 2026 in Review
Raymond James Financial increased its Veracyte (VCYT) stake by 2.7% in Q3 2026, buying an estimated $604K and bringing the position to 484,821 shares worth $22.3M. The position accounts for 0.01% of the portfolio, ranked #1457.
Raymond James Financial first reported a position in VCYT in Q4 2024 and has held it in 8 quarters since. The position peaked at $27.7M in Q2 2026. 383 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.
- Raymond James Financial held 484,821 shares of Veracyte worth $22.3M as of Q3 2026.
- Raymond James Financial bought 12,528 Veracyte shares in Q3 2026, an estimated $604K.
- Veracyte made up 0.01% of Raymond James Financial's portfolio in Q3 2026, its #1457 holding.
- Raymond James Financial first reported a position in Veracyte in Q4 2024 and has held it in 8 quarters since.
- Raymond James Financial's Veracyte position peaked at $27.7M in Q2 2026.
- 383 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.
Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.